Patient satisfaction with 6-month paliperidone palmitate versus other long-acting injectable antipsychotics

被引：0
|
作者：
Perez-Balaguer, A. [1 ]
Garcia del Castillo, I. [1 ]
Gomez-Esteban, B. [1 ]
Vicente-Burguillo, M. [1 ]
Vizcaino-Herrezuelo, H. [2 ]
Castelao-Almodovar, S. [2 ]
Arce de la Riva, A. [2 ]
Neira-Serrano, F. [3 ]
机构：
[1] El Escorial Hosp, Psychiat, Madrid, Spain
[2] Puerta Hierro Univ Hosp, Psychiat, Madrid, Spain
[3] Francisco Vitoria Univ, Stat, Madrid, Spain
来源：
EUROPEAN PSYCHIATRY | 2024年 / 67卷
关键词：
D O I：
10.1192/j.eurpsy.2024.1509
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPV0909
引用
收藏
页码：S726 / S726
页数：1
相关论文
共 50 条
  • [1] Is paliperidone palmitate more effective than other long-acting injectable antipsychotics?
    Patel, R.
    Chesney, E.
    Taylor, M.
    Taylor, D.
    McGuire, P.
    PSYCHOLOGICAL MEDICINE, 2018, 48 (10) : 1616 - 1623
  • [2] Is paliperidone palmitate more effective than other long-acting injectable antipsychotics?
    Desai, Mitesh
    Wooller, Annette
    Lignugaris, Arunas
    Gopal, Srihari
    PSYCHOLOGICAL MEDICINE, 2018, 48 (12) : 2098 - 2099
  • [3] Long-acting injectable paliperidone palmitate in a haemodialysis patient with schizophrenia
    Lin, Jia-Hong
    Tsai, Tsung-Huang
    Lee, Chia-Shun
    Yang, Ya-Hui
    Chen, Kuang-Peng
    Tung, Chun-Liong
    Tsai, Jui-Hsiu
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2021, 55 (08): : 829 - 830
  • [4] Descriptive study of 100 patients with a diagnosis of psychosis treated with Paliperidone Palmitate 6-Month Long-Acting Injectable.
    Mesones, J.
    Miller, A.
    Bautista, N.
    Dieguez, J.
    Calero, I.
    Grinant, A.
    EUROPEAN PSYCHIATRY, 2024, 67 : S387 - S387
  • [5] Use of paliperidone palmitate long-acting injectable in a patient with a personality disorder
    Martinez, N.
    Benitez Cerezo, E.
    Garcia Marin, S.
    EUROPEAN PSYCHIATRY, 2017, 41 : S714 - S714
  • [6] EFFECTIVENESS OF PALIPERIDONE PALMITATE VS OTHER LONG-ACTING INJECTABLE (LAI) ANTIPSYCHOTICS - AN ELECTRONIC CASE REGISTER STUDY
    Patel, Rashmi
    Chesney, Edward
    Taylor, Matthew
    Taylor, David
    McGuire, Philip
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S310 - S311
  • [7] A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia
    Najarian, Dean
    Sanga, Panna
    Wang, Steven
    Lim, Pilar
    Singh, Arun
    Robertson, Mary Jane
    Cohen, Kristin
    Schotte, Alain
    Milz, Ruth
    Venkatasubramanian, Raja
    T'Jollyn, Huybrecht
    Walling, David P.
    Galderisi, Silvana
    Gopal, Srihari
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2022, 25 (03): : 238 - 251
  • [8] Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
    Alphs, Larry
    Bossie, Cynthia A.
    Sliwa, Jennifer Kern
    Fu, Dong-Jing
    Ma, Yi-Wen
    Hulihan, Joseph
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 341 - 350
  • [9] Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France
    Druais, Sylvain
    Doutriaux, Agathe
    Cognet, Magali
    Godet, Annabelle
    Lancon, Christophe
    Levy, Pierre
    Samalin, Ludovic
    Guillon, Pascal
    PHARMACOECONOMICS, 2016, 34 (04) : 363 - 391
  • [10] Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France
    Sylvain Druais
    Agathe Doutriaux
    Magali Cognet
    Annabelle Godet
    Christophe Lançon
    Pierre Levy
    Ludovic Samalin
    Pascal Guillon
    PharmacoEconomics, 2016, 34 : 363 - 391
12345